Back to results
US 9,803,247 B2Granted
MicroRNAs expression signature for determination of tumors origin
AssigneesRosetta Genomics Ltd., Tel Hashomer Medical Infrastructure and Services Ltd.
InventorsNitzan Rosenfeld, Shai Rosenwald, Iris Barshack, Dvora Nass
Life of this patent
Estimating the term…
Abstract
The present invention provides a process for classification of specific cancers and tumors origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
Claims8
A method of distinguishing between a primary gastrointestinal (GI) tumor and a GI metastatic tumor, the method comprising:
- (a) providing RNA from a biological sample obtained from a human subject;
- (b) determining an expression profile of nucleic acids consisting of SEQ ID NOS:
- 1 and 4, by contacting the RNA with probes consisting of (i) a first nucleic acid probe, wherein the sequence of the first nucleic acid probe consists of the complement of SEQ ID NO:
- 1 and a linker of 10-60 nucleotides on the 3′ end of the complement of SEQ ID NO:
- 1;
- (ii) a second nucleic acid probe, wherein the sequence of the second nucleic acid probe consists of the complement of SEQ ID NO:
- 4 and a linker of 10-60 nucleotides at the 3′ end of the complement of SEQ ID NO:
- 4;
- and (iii) optionally a control probe;
- wherein the probes are attached to a solid support;
- (c) comparing the expression profile from the biological sample to a reference expression profile;
- and
- (d) distinguishing the biological sample as a primary GI tumor or a GI metastatic tumor based on the comparison of the expression profiles.
10 more elements
Dependencies are inferred from the claim text.